Carcinine

Evidence: Mixed
SpecialtyCarnosine analog

Useful mainly for no established oral use; promoted as a topical anti-aging antioxidant.

Quick decision guide

May help most

no established oral use; promoted as a topical anti-aging antioxidant

Common dosing range

Not established for oral use

When to expect effects

Not characterized

Watch out for

Essentially unstudied as an oral supplement; evidence is in-vitro and cosmetic

What is it

Carcinine is a naturally occurring imidazole dipeptide closely related to carnosine, marketed (under names like Glycoxil) mainly as a topical cosmetic antioxidant and anti-glycation ingredient. Its evidence is largely laboratory-based, and it has essentially no clinical research as an oral dietary supplement.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You are evaluating it as a topical cosmetic ingredient and accept lab-level evidence

Probably skip if

You want an evidence-based oral antioxidant — carnosine itself is better studied
You expect proven anti-aging or systemic benefits
You are pregnant or breastfeeding

Evidence at a glance

GoalEvidenceEffectBest fitTime
antioxidant and anti-glycation activityMixedNot established in humansnot defined for oral useNot characterized

Evidence for 1 use

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

antioxidant and anti-glycation activity

Mechanism only
Mixed

As a carnosine-related dipeptide, carcinine scavenges reactive oxygen species and inhibits the formation of advanced glycation end-products in laboratory and skin-model systems, which is the basis for its use in cosmetics. There are no controlled trials of oral carcinine, so any systemic supplement benefit is unproven; the better-studied analog is carnosine.

Effect size: Not established in humans
Time to effect: Not characterized
Best fit: not defined for oral use

Bottom line: A carnosine-like antioxidant with cosmetic and lab support but no oral supplement evidence.

How to take it

Typical dose
No established oral dose; used as a topical cosmetic ingredient
Timing
Not characterized for oral use
With food
Not characterized

What to track

  • nothing validated for oral use

Safety

Common side effects

not characterized for oral use

Who should avoid it

  • pregnant or breastfeeding women
  • anyone seeking oral use given the absence of safety data

Pregnancy & breastfeeding

Avoid oral use in pregnancy and breastfeeding due to lack of data.

Choosing a product

Look for

  • clear indication of intended use (topical vs oral)
  • identity and concentration

Be skeptical of

  • systemic anti-aging or longevity claims
  • implying oral efficacy that has not been studied

References by claim

antioxidant and anti-glycation activity

  • Babizhayev et al., 2012PubMed (2012) link
  • Babizhayev et al., 2012PubMed (2012) link

Track Carcinine with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.

Carcinine: Benefits, Dosage, Timing & Evidence | Pilora